Mode
Text Size
Log in / Sign up
N/A N=100

Evaluation of the Benefits for Overall Health Following Cochlear Implant Treatment in the Elderly Population

Hearing Loss

Enrolled (actual)
100
Serious AEs
2.0%
Results posted
Jan 2024
Primary outcome: Primary: Change in Health Related Quality of Life Following Cochlear Implant Treatment — 0.14; 0.22; 0.08 units on a scale

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Commercial Nucleus Cochlear Implant Systems (Device)
Age
Adult, Older Adult · 60+ yrs
Sex
All
Sponsor
Cochlear
Primary completion
Mar 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Health Related Quality of Life Following Cochlear Implant Treatment
0.13; 0.25; 0.08
PRIMARY
Change in Health Related Quality of Life Following Cochlear Implant Treatment
0.13; 0.25; 0.08

Summary

The purpose of this study is to show that cochlear implant treatment improves the overall health related quality of life and general well-being in elderly individuals.

Eligibility Criteria

Inclusion Criteria

  • Unilateral CI candidates with bilateral post-lingual deafness with intention to treat
  • ≥ 60 years at first unilateral cochlear implant
  • Implant ear: meets all local criteria for cochlear implant treatment
  • Contralateral ear: average pure tone thresholds indicate a moderately-severe to profound hearing loss (4 freq. average: 0.5, 1, 2 and 3 or 4 kHz > 56 dBHL).
  • Willingness to participate in and to comply with all study procedures
  • Fluency in languages used to assess clinical performance
  • Appropriate expectations from routine cochlear implant treatment
  • Able to decide on study participation personally and independently sign their consent

Exclusion Criteria

  • Significantly/severely dependent or fragile
  • Unable to provide consent personally
  • Unable to complete questionnaires for self-assessment independently
  • Unilateral hearing loss
  • Sequential and simultaneous bilateral cochlear implant recipients
  • Ossification or other cochlear anomalies preventing full electrode insertion
  • Retro cochlear or central origins of hearing impairment.
  • Significant comorbidities preventing study participation (e.g. blindness, immobility or in a wheel chair, severe aphasia)
  • Medical contraindications to surgery
  • Clinic Standard fail criteria for cochlear implant candidacy in regards to chronic depression, dementia, and cognitive disorders.
  • Unrealistic expectations on the part of the subject, regarding the possible benefits, risks and limitations that are inherent to the procedure and prosthetic device.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03072862). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search